Data gathered: May 17
Alternative Data for Teva Pharmaceutical
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 633 | Sign up | Sign up | Sign up |
| Sentiment | 91 | Sign up | Sign up | Sign up |
| Webpage traffic | 302,000 | Sign up | Sign up | Sign up |
| Employee Rating | 74 | Sign up | Sign up | Sign up |
| Google Trends | 28 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 5,765 | Sign up | Sign up | Sign up |
| Facebook Followers | 54,533 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 14 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 26,198 | Sign up | Sign up | Sign up |
| Twitter Followers | 10,552 | Sign up | Sign up | Sign up |
| Twitter Mentions | 63 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 7,720 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | 74 | Sign up | Sign up | Sign up |
| Business Outlook | 59 | Sign up | Sign up | Sign up |
| Linkedin Employees | 27,972 | Sign up | Sign up | Sign up |
About Teva Pharmaceutical
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
| Price | $16.30 |
| Target Price | Sign up |
| Volume | 16,160,000 |
| Market Cap | $19.4B |
| Year Range | $8.12 - $17.09 |
| Dividend Yield | 0% |
| PE Ratio | 30.17 |
| Revenue per Employee | $400,325 |
| Industry | Drug Manufacturers |
In the news
 |
Teva Pharmaceutical Industries (NYSE:TEVA) Sets New 12-Month High at $17.09May 16 - ETF Daily News |
 |
Teva Pharmaceutical names new EVP for global operationsMay 15 - Investing.com |
|
Teacher Retirement System of Texas Trims Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)May 15 - ETF Daily News |
Teva Pharmaceutical Welcomes New EVP Amid Leadership ChangesMay 14 - TipRanks |
|
David Abrams Exits Teva Pharmaceutical in Q1 2024, Reflecting Strategic Portfolio AdjustmentsMay 14 - Yahoo Entertainment |
|
 |
Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded to Buy at StockNews.comMay 14 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 3.82B | 3.9B | 1.77B | -139M | 54M | 0.000 |
| Q4 '23 | 3.48B | 3.84B | 2.42B | 429M | 988M | 1.000 |
| Q3 '23 | 3.85B | 3.2B | 1.85B | 70M | 638M | 0.600 |
| Q2 '23 | 3.88B | 4.08B | 1.8B | -871M | -346M | 0.560 |
| Q1 '23 | 3.66B | 3.47B | 1.58B | -220M | 306M | 0.400 |
Insider Transactions View All
| Kalif Eliyahu Sharon filed to sell 203,691 shares at $13.5. March 7 '24 |
| Conway Vikki L filed to sell 15,219 shares at $13.5. March 7 '24 |
| Daniell Richard filed to sell 69,770 shares at $13.5. March 7 '24 |
| Daniell Richard filed to sell 98,943 shares at $13.5. March 7 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$154.28 0% | 60 |
 |
Eli Lilly and CompanyLLY |
$771.12 0% | 71 |
 |
PfizerPFE |
$28.92 0% | 39 |
 |
AstrazenecaAZN |
$77.04 0% | 58 |
 |
AbbVieABBV |
$164.33 0% | 58 |
Read more about Teva Pharmaceutical (TEVA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Teva Pharmaceutical?
The Market Cap of Teva Pharmaceutical is $19.4B.
What is Teva Pharmaceutical's PE Ratio?
As of today, Teva Pharmaceutical's PE (Price to Earnings) ratio is 30.17.
How Many People Work at Teva Pharmaceutical?
As of our latest update, Teva Pharmaceutical employed approximately 37,537 people worldwide. However, it's important to note that Teva Pharmaceutical's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Teva Pharmaceutical's revenue per employee?
$400,325. To calculate Teva Pharmaceutical's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Teva Pharmaceutical?
Currently, the price of one share of Teva Pharmaceutical stock is $16.30.
How can I analyze the TEVA stock price chart for investment decisions?
The TEVA stock price chart above provides a comprehensive visual representation of Teva Pharmaceutical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Teva Pharmaceutical shares. Our platform offers an up-to-date TEVA stock price chart, along with technical data analysis and alternative data insights.
Does TEVA offer dividends to its shareholders?
As of our latest update, Teva Pharmaceutical (TEVA) does not offer dividends to its shareholders. Investors interested in Teva Pharmaceutical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Teva Pharmaceutical?
Some of the similar stocks of Teva Pharmaceutical are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.